Background Inflammatory and proteolytic activity occurs in sputum from patients with stable purulent bronchiectasis and has been proposed as the main pathogenetic mechanism of the disease. This study was designed to define further the role of inflammation and proteolysis in bronchiectasis. Methods Neutrophil elastase activity, sputum concentrations of the serum derived inhibitors al antiproteinase and a2 macroglobulin, and the sputum to serum ratios of albumin and C reactive protein concentration were measured in 26 patients with bronchiectasis. Results Free elastase activity was found in 15 sputum samples. A trend to higher proteolytic and inflammatory activity was found between mucoid and purulent sputum samples, suggesting that inflammatory and proteolytic activities are related to the macroscopic degree of purulence. Purulent sputum had a high sputum to serum ratio of C reactive protein, suggesting local production or active transport of this protein into bronchial secretions. C reactive protein was more sensitive than albumin in detecting a higher degree of inflammation in elastase positive samples. Conclusion The finding of greater concentrations of a2 macroglobulin in purulent and elastase positive samples than in mucopurulent, mucoid and elastase negative sputum samples suggests that this inhibitor may have a role in the proteolysis-antiproteolysis balance in bronchial secretions. 
vitro. 34 The presence of free elastolytic activity in lung secretions implies a defective inhibition of elastase by its inhibitors, which have been underinvestigated in bronchiectasis. Inflammation in chronic bronchial sepsis has been assessed by the sputum to serum ratio of albumin concentration,56 although others have suggested that measurements of C reactive protein, a simple screening test for active inflammation, might be a useful marker for chronic bronchial sepsis.7 8 To define further the role of inflammation and proteolysis in stable bronchiectasis we measured proteolytic activity in sputum, determined the concentration of the serum derived inhibitors a, antiproteinase and a2 macroglobulin in sputum and measured C reactive protein concentration in sputum as a marker of bronchial inflammation.
Patients and methods Twenty six outpatients with bronchiectasis were studied during a stable clinical phase of their disease. Diagnosis of bronchiectasis was based on a positive bronchogram or on the daily production of purulent sputum and a chest radiograph suggestive of bronchiectasis. All patients gave informed consent to the study. Sputum was collected over four hours after waking. The (0-33-3-9) x 10-2 and 1-4 (0-62-3-5) x 10'2 mg/dl respectively), but it was lower in mucoid samples (0-35 (0 26-0 90) x 10-2) than in the Sputum to serum ratio of C reactive protein corrected for albumin was similar in purulent and mucopurulent samples (126 (7-8-314) x 10-2) and (232 (0-577) x 10-2) respectively) and was greater in both groups than in mucoid samples when C reactive protein was not detectable (table 2, figure 1) . It was greater in elastase positive (139 (7T8-577) 10-2) than elastase negative samples (6-8 (0-239) 10-2; p < 0-03) (table 3, figure 2 ). SERUM DERIVED INHIBITORS (table 2, figure 3) cxl Antiproteinase The sputum to serum ratio of a, antiproteinase corrected for the albumin ratio was similar in purulent, mucopurulent, and mucoid samples (3 4 (0-9-9-3) x 10-2, 3-5 (0-9-6 5) x 10-2, and 1-52 (0-3-7) x 10-2 respectively; p < 0-08). The ratio corrected for albumin was similar in samples with or without elastase activity (3-4 (0 9-93) x 10-2 and 29 (0-3-8) x 10-2 respectively).
a2 Macroglobulin The sputum to serum ratio of a2 macroglobulin corrected for albumin was greater (p < 04008) in purulent samples (2 (1 - 18-24-6) x 10-2) than in mucopurulent (0 05 (0-28) x 10-2) or mucoid samples (0; p < 04002). It was greater in elastase positive than in elastase negative samples (2-3 (0-246) x 10-2 and 0-06 (0-16) x 10-2 respectively; p < 0403).
Discussion
An increased sputum to serum albumin ratio may be a feature of the inflammatory response to infection in the lung.69 In our patients this ratio was higher, although not significantly so, in patients with purulent sputum than in those with mucopurulent sputum; it was significantly less in patients with mucoid sputum than in patients with purulent or mucopurulent sputum, suggesting an association between macroscopic purulence and inflammation. The mean values for sputum to serum albumin ratios in our patients were similar to those found in other studies of patients with stable bronchiectasis and cystic fibrosis.5 69 The sputum to serum albumin ratio was also higher, but not significantly so, in patients with elastase positive sputum than in those with elastase negative sputum.
C reactive protein is a pentameric protein synthesised in the liver whose function is unknown, though it may help in removing autogenous and exogenous material from the circulation. This may be its main role in infection, when it acts as a broad spectrum mechanism in recognising products of pathogenetic microorganisms. A raised concentration of this protein is considered to be unequivocal evidence of active tissue destruction,10 but this protein has not yet been assessed as an index of active inflammation in bronchiectasis. We measured the serum and sputum concentrations of C reactive protein in our patients with bronchiectasis and calculated the sputum to serum ratio, after correcting for the albumin ratio, albumin being used as the reference protein.
The ratio for C reactive protein, corrected for the albumin ratio, was similar in purulent and mucopurulent samples. Interestingly, C reactive protein was not detectable in any mucoid sample. The high ratio of sputum to serum C reactive protein corrected for the albumin ratio suggests local production of this protein or a mechanism of active transport from the circulation to the bronchial tree. The high value of the C reactive protein ratio in purulent and mucopurulent sputum from patients with clinically stable bronchiectasis is consistent with the high albumin concentration in the sputum of these patients; C reactive protein is thus another marker of bronchial inflammation in sputum, but it may have other pathogenetic implications in the disease. C reactive protein was also found in significantly greater concentration in elastase positive sputum than in elastase negative sputum, whereas the albumin ratio did not differ significantly in these two groups. a, Antiproteinase and a2 macroglobulin are the main serum antiproteases" in bronchial secretions. They gain entry mainly by passive diffusion from the circulation. This is true for cxl antiproteinase, though additional local production of a2 macroglobulin by alveolar macrophages may occur.9 11 12Our patients with bronchiectasis showed higher sputum to serum ratios of a, antiproteinase and c2 macroglobulin than would be expected by simple diffusion, suggesting some local production for both inhibitors.6 Direct evidence of local production for a, antiproteinase does not exist, although alveolar macrophages can synthesise this protein in vitro. Our findings suggest the possibility that both inhibitors are produced locally, although overestimation of cx, antiproteinase concentration in the bronchial secretions of patients with cystic fibrosis have been reported with this method of measurement.5 Despite these considerations, our finding of a higher ratio of a2 macroglobulin in elastase positive and in purulent secretions than in elastase negative, mucopurulent, and mucoid samples suggests a more important role for this inhibitor than has been previously considered. Increased synthesis of a2 macroglobulin in compensation for an insufficient antiproteolytic effect of a, antiproteinase in the presence of increased elastolytic activity might account for these findings. The high concentrations of a2 macroglobulin can also be attributed to an increased synthesis in lymphoid tissues, due to a chronic inflammatory stimulus in the lung. ' 
